Metastatic amelanotic nodular melanoma during pregnancy

Medicina

Volumn 44, Issue 6, 2008, Pages 467-471

  Jasaitiene, Daiva ^a   Valiukevičiene, Skaidra ^a   Makštiene, Jurgita ^a   Juodžbaliene, Edita Brone ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Amelanotic melanoma; Metastatic melanoma; Pregnancy; Therapy

Indexed keywords

ADULT; AMELANOTIC MELANOMA; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METASTASIS; MORTALITY; NEWBORN; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PROGNOSIS; PUERPERAL DISORDER; SECOND TRIMESTER PREGNANCY; SKIN; SKIN TUMOR; THIRD TRIMESTER PREGNANCY; TIME;

ADULT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA, AMELANOTIC; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PROGNOSIS; PUERPERAL DISORDERS; SKIN; SKIN NEOPLASMS; TIME FACTORS;

EID: 53049102524     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina44060061     Document Type: Article

References (25)

1. World Health Organization. The International Statistical Classification of Diseases and Related Health Problems, 10th revision. Geneva, Switzerland: World Health Organization; 1992.
2. Stang A, Valiukeviciene S, Aleknaviciene B, Kurtinaitis J. Time trends of incidence, mortality, and relative survival of skin melanoma in Lithuania. Eur J Cancer 2006;42:660-7.
3. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: Results of linkage with the California cancer registry. Am J Obstet Gynecol 2003;189:1128-35.
4. Alexander A, Samlowski WE, Grossmen D, Bruggers CS, Harris RM, Zone JJ, et al. Metastatic melanoma in pregnancy: Risk of transplacental metastases in the infant. J Clin Oncol 2003;21:2179-86.
5. O'Reilly S, Chakravarthy A. Other cancers in pregnancy. In: Trimble E, Trimble C, editors. Cancer obstetrics and gynecology. Philadelphia: Lippincott Williams and Wilkins; 1999. p. 249-59.
6. Zalaudek I, Argenziano G, Kerl H, Soyer HP. Amelanotic/hypomelanotic melanoma - is dermatoscopy useful for diagnosis? J Dtsch Dermatol Ges 2003;1:369-73.
7. Pack GT, Scharnagel IM. The prognosis for malignant melanoma in the pregnant woman. Cancer 1951;4:324-34.
8. O'Meara AT, Cress R, Xing G, Danielsen B, Smith LH. Malignant melanoma in pregnancy. A population-based evaluation. Cancer 2005;103:1217-26.
9. Driscoll MS, Grant-Kels JM. Hormones, nevi, and melanoma: An approach to the patient. J Am Acad Dermatol 2007;57:919-31.
10. Lens MB, Rosdahl I, Ahlbom A, Farahmand BY, Synnerstad I, Boeryd B, et al. Effect of pregnancy on survival in women with cutaneous malignant melanoma. J Clin Oncol 2004;22: 4369-75.
11. Travers RL, Sober AJ, Berwick M, Mihm MCJr, Barnhill RL, Duncan LM. Increased thickness of pregnancy-associated melanoma. Br J Dermatol 1995;132:876-83.
12. MacKie RM, Bufalino R, Morabito A, Sutherland C, Cascinelli N. Lack of effect of pregnancy on outcome of melanoma. For the World Health Organization Melanoma Programme. Lancet 1991;337:653-5.
13. Beyeler M, Hafner J, Beinder E, Fauchere JC, Stoeckli SJ, Fehr M, et al. Special considerations for stage IV melanoma during pregnancy. Arch Dermatol 2005;141:1077-9.
14. Johnson SRD. What should we tell patients about hormones after having melanoma? In: Newton Bishop JA, Gore M,Ceditors. Melanoma: critical debates. Oxford: Blackwell Science; 2002. p. 275-6.
15. Dipaola RS, Goodin S, Ratzell M, Florczyk M, Karp G, Ravikumar TS. Chemotherapy for metastatic melanoma during pregnancy. Gynecol Oncol 1997;66:526-30.
16. Egberts F, Lischner S, Russo P, Kampen WU, Hauschild A. Diagnostic and therapeutic procedures for management of melanoma during pregnancy: Risk for the fetus? J Dtsch Dermatol Ges 2006;4:717-20.
17. Leyendecker JR, Gorengaut V, Brown JJ. MR imaging of maternal diseases of the abdomen and pelvis during pregnancy and the immediate postpartum period. Radiographics 2004; 24(5):1301-16.
18. Oto A, Ernst R, Jesse MK, Chaljub G, Saade G. Magnetic resonance imaging of the chest, abdomen, and pelvis in the evaluation of pregnant patients with neoplasms. Am J Perinatol 2007;24(4):243-50.
19. Mondi MM, Cuenca RE, Ollila DW, Stewart JH 4th, Levine EA. Sentinel lymph node biopsy during pregnancy: Initial clinical experience. Ann Surg Oncol 2007;14(1):218-21.
20. Lloyd MS, Topping A, Allan R, Powell B. Contraindications to sentinel lymph node biopsy in cutaneous malignant melanoma. Br J Plast Surg 2004;57:725-7.
21. Kaikaris V, Valiukeviciene S, Rimdeika R, Gollnick H, Ulrich J. Sentinel lymph node biopsy in melanoma patients: Methods, indications, and clinical significance. Medicina (Kaunas) 2003;7:621-30.
22. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, et al. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 1994;368:237-9.
23. LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 2002;62:3691-7.
24. Hoshimoto K, Hayashi M, Ohkura T. Plasma levels of soluble Fas during normal pregnancy. Gynecol Obstet Invest 2001; 51:96-8.
25. Alexander A, Harris RM, Grossman D, Bruggers CS, Leachman SA. Vulvar melanoma: Diffuse melanosis and metastasis to the placenta. J Am Acad Dermatol 2004;50:293-8.